Type I interferons (IFNs) can reprogram the cholesterol biosynthetic pathway to facilitate innate immune responses. In this issue of Immunity, Xiao et al. (2020) reveal that type I IFN signaling and 7-dehydrocholesterol (7-DHC) accumulation form a positive feedback loop to amplify innate immune responses to control viral infections by activating AKT3.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.immuni.2019.12.017 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!